GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanadaBis Capital Inc (TSXV:CANB) » Definitions » EBITDA Margin %

CanadaBis Capital (TSXV:CANB) EBITDA Margin % : 10.91% (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is CanadaBis Capital EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. CanadaBis Capital's EBITDA for the three months ended in Jan. 2024 was C$0.47 Mil. CanadaBis Capital's Revenue for the three months ended in Jan. 2024 was C$4.31 Mil. Therefore, CanadaBis Capital's EBITDA margin for the quarter that ended in Jan. 2024 was 10.91%.


CanadaBis Capital EBITDA Margin % Historical Data

The historical data trend for CanadaBis Capital's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanadaBis Capital EBITDA Margin % Chart

CanadaBis Capital Annual Data
Trend Nov16 Dec17 Dec18 Jul19 Jul20 Jul21 Jul22 Jul23
EBITDA Margin %
Get a 7-Day Free Trial - -108.04 -26.39 13.96 25.55

CanadaBis Capital Quarterly Data
Mar19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.42 24.53 34.78 19.14 10.91

Competitive Comparison of CanadaBis Capital's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanadaBis Capital's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where CanadaBis Capital's EBITDA Margin % falls into.



CanadaBis Capital EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

CanadaBis Capital's EBITDA Margin % for the fiscal year that ended in Jul. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Jul. 2023 )/Revenue (A: Jul. 2023 )
=5.678/22.222
=25.55 %

CanadaBis Capital's EBITDA Margin % for the quarter that ended in Jan. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=0.47/4.309
=10.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CanadaBis Capital  (TSXV:CANB) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


CanadaBis Capital EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of CanadaBis Capital's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


CanadaBis Capital (TSXV:CANB) Business Description

Traded in Other Exchanges
Address
PO Box 850, Rocky Mountain House, AB, CAN, T4T 1A6
CanadaBis Capital Inc is a vertically-integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extraction and tolling. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premise owned and operated by the Company. Extraction and tolling segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extraction and tolling.
Executives
Garfield Richards Senior Officer

CanadaBis Capital (TSXV:CANB) Headlines

From GuruFocus